Abingdon Health Plc (AIM:ABDX)
10.00
+0.15 (1.52%)
Jul 28, 2026, 8:07 AM GMT
Abingdon Health Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 3.71 | 1.92 | 1.44 | 3.24 | 2.4 | 4.98 |
Cash & Short-Term Investments | 3.71 | 1.92 | 1.44 | 3.24 | 2.4 | 4.98 |
Cash Growth | 93.27% | 33.19% | -55.50% | 35.00% | -51.84% | 13.42% |
Accounts Receivable | 1.95 | 2.45 | 1.47 | 1.15 | 7.84 | 9.98 |
Inventory | 0.64 | 0.53 | 0.44 | 0.33 | 0.53 | 7.89 |
Other Current Assets | 0.41 | 0.24 | 0.2 | 0.05 | 0.18 | 0.12 |
Total Current Assets | 6.7 | 5.13 | 3.55 | 4.76 | 10.96 | 22.96 |
Net Property, Plant & Equipment | 0.78 | 1.04 | 1 | 1.26 | 1.84 | 9.04 |
Other Intangible Assets | 0.44 | 0.5 | 0.15 | 0.09 | 0.04 | 0.47 |
Goodwill | 2.28 | 2.28 | 0.38 | - | - | 0.76 |
Long-Term Investments | 0.35 | 0.35 | 0.01 | - | - | - |
Total Assets | 10.55 | 9.31 | 5.09 | 6.11 | 12.83 | 33.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 3.21 | 2.66 | 1.7 | 2.03 | 5.06 | 10.41 |
Current Portion of Long-Term Debt | 0.13 | 0.09 | - | - | 0.12 | 0.13 |
Current Portion of Leases | 0.16 | 0.17 | 0.12 | 0.09 | 0.15 | 0.23 |
Total Current Liabilities | 3.5 | 2.92 | 1.82 | 2.12 | 5.32 | 10.76 |
Long-Term Debt | 0.62 | 0.65 | 0.72 | 0.71 | 0.44 | 0.37 |
Long-Term Leases | 0.04 | 0.12 | 0.21 | 0.22 | 0.58 | 0.78 |
Other Long-Term Liabilities | 0.09 | 0.33 | 0.09 | 0.09 | 0.08 | - |
Total Long-Term Liabilities | 0.75 | 1.09 | 1.02 | 1.02 | 1.1 | 1.14 |
Total Liabilities | 4.25 | 4.01 | 2.84 | 3.14 | 6.42 | 11.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0.11 | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 |
Additional Paid-in Capital | 40.23 | 37.04 | 30.81 | 30.31 | 30.31 | 24.18 |
Accumulated Other Comprehensive Income | 0.49 | 0.34 | 0.12 | 0.08 | 0.15 | 0.04 |
Retained Earnings | -34.52 | -32.17 | -28.76 | -27.49 | -24.13 | -2.97 |
Shareholders' Equity | 6.3 | 5.3 | 2.25 | 2.97 | 6.41 | 21.33 |
Total Liabilities & Equity | 10.55 | 9.31 | 5.09 | 6.11 | 12.83 | 33.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.95 | 1.03 | 1.05 | 1.02 | 1.28 | 1.5 |
Net Cash (Debt) | 2.76 | 0.89 | 0.39 | 2.22 | 1.12 | 3.48 |
Net Cash Growth | 210.00% | 127.62% | -82.36% | 98.48% | -67.92% | - |
Net Cash Per Share | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
Book Value | 6.3 | 5.3 | 2.25 | 2.97 | 6.41 | 21.33 |
Book Value Per Share | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.08 |
Tangible Book Value | 3.58 | 2.52 | 1.72 | 2.88 | 6.38 | 20.1 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.08 |